IBDEI2KM ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41031,1,4,0)
;;=4^A81.9
;;^UTILITY(U,$J,358.3,41031,2)
;;=^5000414
;;^UTILITY(U,$J,358.3,41032,0)
;;=A81.09^^152^2020^8
;;^UTILITY(U,$J,358.3,41032,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41032,1,3,0)
;;=3^Creutzfeldt-Jakob Disease NEC
;;^UTILITY(U,$J,358.3,41032,1,4,0)
;;=4^A81.09
;;^UTILITY(U,$J,358.3,41032,2)
;;=^5000410
;;^UTILITY(U,$J,358.3,41033,0)
;;=A81.00^^152^2020^9
;;^UTILITY(U,$J,358.3,41033,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41033,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Unspec
;;^UTILITY(U,$J,358.3,41033,1,4,0)
;;=4^A81.00
;;^UTILITY(U,$J,358.3,41033,2)
;;=^5000409
;;^UTILITY(U,$J,358.3,41034,0)
;;=A81.01^^152^2020^10
;;^UTILITY(U,$J,358.3,41034,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41034,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Variant
;;^UTILITY(U,$J,358.3,41034,1,4,0)
;;=4^A81.01
;;^UTILITY(U,$J,358.3,41034,2)
;;=^336701
;;^UTILITY(U,$J,358.3,41035,0)
;;=A81.89^^152^2020^7
;;^UTILITY(U,$J,358.3,41035,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41035,1,3,0)
;;=3^Atypical Virus Infections of CNS NEC
;;^UTILITY(U,$J,358.3,41035,1,4,0)
;;=4^A81.89
;;^UTILITY(U,$J,358.3,41035,2)
;;=^5000413
;;^UTILITY(U,$J,358.3,41036,0)
;;=A81.2^^152^2020^27
;;^UTILITY(U,$J,358.3,41036,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41036,1,3,0)
;;=3^Progressive Multifocal Leukoencephalopathy
;;^UTILITY(U,$J,358.3,41036,1,4,0)
;;=4^A81.2
;;^UTILITY(U,$J,358.3,41036,2)
;;=^5000411
;;^UTILITY(U,$J,358.3,41037,0)
;;=B20.^^152^2020^17
;;^UTILITY(U,$J,358.3,41037,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41037,1,3,0)
;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
;;^UTILITY(U,$J,358.3,41037,1,4,0)
;;=4^B20.
;;^UTILITY(U,$J,358.3,41037,2)
;;=^5000555^F02.81
;;^UTILITY(U,$J,358.3,41038,0)
;;=B20.^^152^2020^18
;;^UTILITY(U,$J,358.3,41038,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41038,1,3,0)
;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
;;^UTILITY(U,$J,358.3,41038,1,4,0)
;;=4^B20.
;;^UTILITY(U,$J,358.3,41038,2)
;;=^5000555^F02.80
;;^UTILITY(U,$J,358.3,41039,0)
;;=F10.27^^152^2020^1
;;^UTILITY(U,$J,358.3,41039,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41039,1,3,0)
;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
;;^UTILITY(U,$J,358.3,41039,1,4,0)
;;=4^F10.27
;;^UTILITY(U,$J,358.3,41039,2)
;;=^5003095
;;^UTILITY(U,$J,358.3,41040,0)
;;=F19.97^^152^2020^29
;;^UTILITY(U,$J,358.3,41040,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41040,1,3,0)
;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
;;^UTILITY(U,$J,358.3,41040,1,4,0)
;;=4^F19.97
;;^UTILITY(U,$J,358.3,41040,2)
;;=^5003465
;;^UTILITY(U,$J,358.3,41041,0)
;;=F03.90^^152^2020^15
;;^UTILITY(U,$J,358.3,41041,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41041,1,3,0)
;;=3^Dementia w/o Behavioral Disturbance,Unspec
;;^UTILITY(U,$J,358.3,41041,1,4,0)
;;=4^F03.90
;;^UTILITY(U,$J,358.3,41041,2)
;;=^5003050
;;^UTILITY(U,$J,358.3,41042,0)
;;=G30.0^^152^2020^2
;;^UTILITY(U,$J,358.3,41042,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41042,1,3,0)
;;=3^Alzheimer's Disease w/ Early Onset
;;^UTILITY(U,$J,358.3,41042,1,4,0)
;;=4^G30.0
;;^UTILITY(U,$J,358.3,41042,2)
;;=^5003805
;;^UTILITY(U,$J,358.3,41043,0)
;;=G30.1^^152^2020^3
;;^UTILITY(U,$J,358.3,41043,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41043,1,3,0)
;;=3^Alzheimer's Disease w/ Late Onset
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2KM 3801 printed Apr 09, 2024@21:41:59 Page 2
IBDEI2KM ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41031,1,4,0)
+2 ;;=4^A81.9
+3 ;;^UTILITY(U,$J,358.3,41031,2)
+4 ;;=^5000414
+5 ;;^UTILITY(U,$J,358.3,41032,0)
+6 ;;=A81.09^^152^2020^8
+7 ;;^UTILITY(U,$J,358.3,41032,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,41032,1,3,0)
+10 ;;=3^Creutzfeldt-Jakob Disease NEC
+11 ;;^UTILITY(U,$J,358.3,41032,1,4,0)
+12 ;;=4^A81.09
+13 ;;^UTILITY(U,$J,358.3,41032,2)
+14 ;;=^5000410
+15 ;;^UTILITY(U,$J,358.3,41033,0)
+16 ;;=A81.00^^152^2020^9
+17 ;;^UTILITY(U,$J,358.3,41033,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,41033,1,3,0)
+20 ;;=3^Creutzfeldt-Jakob Disease,Unspec
+21 ;;^UTILITY(U,$J,358.3,41033,1,4,0)
+22 ;;=4^A81.00
+23 ;;^UTILITY(U,$J,358.3,41033,2)
+24 ;;=^5000409
+25 ;;^UTILITY(U,$J,358.3,41034,0)
+26 ;;=A81.01^^152^2020^10
+27 ;;^UTILITY(U,$J,358.3,41034,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,41034,1,3,0)
+30 ;;=3^Creutzfeldt-Jakob Disease,Variant
+31 ;;^UTILITY(U,$J,358.3,41034,1,4,0)
+32 ;;=4^A81.01
+33 ;;^UTILITY(U,$J,358.3,41034,2)
+34 ;;=^336701
+35 ;;^UTILITY(U,$J,358.3,41035,0)
+36 ;;=A81.89^^152^2020^7
+37 ;;^UTILITY(U,$J,358.3,41035,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,41035,1,3,0)
+40 ;;=3^Atypical Virus Infections of CNS NEC
+41 ;;^UTILITY(U,$J,358.3,41035,1,4,0)
+42 ;;=4^A81.89
+43 ;;^UTILITY(U,$J,358.3,41035,2)
+44 ;;=^5000413
+45 ;;^UTILITY(U,$J,358.3,41036,0)
+46 ;;=A81.2^^152^2020^27
+47 ;;^UTILITY(U,$J,358.3,41036,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,41036,1,3,0)
+50 ;;=3^Progressive Multifocal Leukoencephalopathy
+51 ;;^UTILITY(U,$J,358.3,41036,1,4,0)
+52 ;;=4^A81.2
+53 ;;^UTILITY(U,$J,358.3,41036,2)
+54 ;;=^5000411
+55 ;;^UTILITY(U,$J,358.3,41037,0)
+56 ;;=B20.^^152^2020^17
+57 ;;^UTILITY(U,$J,358.3,41037,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,41037,1,3,0)
+60 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
+61 ;;^UTILITY(U,$J,358.3,41037,1,4,0)
+62 ;;=4^B20.
+63 ;;^UTILITY(U,$J,358.3,41037,2)
+64 ;;=^5000555^F02.81
+65 ;;^UTILITY(U,$J,358.3,41038,0)
+66 ;;=B20.^^152^2020^18
+67 ;;^UTILITY(U,$J,358.3,41038,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,41038,1,3,0)
+70 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
+71 ;;^UTILITY(U,$J,358.3,41038,1,4,0)
+72 ;;=4^B20.
+73 ;;^UTILITY(U,$J,358.3,41038,2)
+74 ;;=^5000555^F02.80
+75 ;;^UTILITY(U,$J,358.3,41039,0)
+76 ;;=F10.27^^152^2020^1
+77 ;;^UTILITY(U,$J,358.3,41039,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,41039,1,3,0)
+80 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
+81 ;;^UTILITY(U,$J,358.3,41039,1,4,0)
+82 ;;=4^F10.27
+83 ;;^UTILITY(U,$J,358.3,41039,2)
+84 ;;=^5003095
+85 ;;^UTILITY(U,$J,358.3,41040,0)
+86 ;;=F19.97^^152^2020^29
+87 ;;^UTILITY(U,$J,358.3,41040,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,41040,1,3,0)
+90 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
+91 ;;^UTILITY(U,$J,358.3,41040,1,4,0)
+92 ;;=4^F19.97
+93 ;;^UTILITY(U,$J,358.3,41040,2)
+94 ;;=^5003465
+95 ;;^UTILITY(U,$J,358.3,41041,0)
+96 ;;=F03.90^^152^2020^15
+97 ;;^UTILITY(U,$J,358.3,41041,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,41041,1,3,0)
+100 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
+101 ;;^UTILITY(U,$J,358.3,41041,1,4,0)
+102 ;;=4^F03.90
+103 ;;^UTILITY(U,$J,358.3,41041,2)
+104 ;;=^5003050
+105 ;;^UTILITY(U,$J,358.3,41042,0)
+106 ;;=G30.0^^152^2020^2
+107 ;;^UTILITY(U,$J,358.3,41042,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,41042,1,3,0)
+110 ;;=3^Alzheimer's Disease w/ Early Onset
+111 ;;^UTILITY(U,$J,358.3,41042,1,4,0)
+112 ;;=4^G30.0
+113 ;;^UTILITY(U,$J,358.3,41042,2)
+114 ;;=^5003805
+115 ;;^UTILITY(U,$J,358.3,41043,0)
+116 ;;=G30.1^^152^2020^3
+117 ;;^UTILITY(U,$J,358.3,41043,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,41043,1,3,0)
+120 ;;=3^Alzheimer's Disease w/ Late Onset
